dc.contributor.author | Fineberg, Naomi | |
dc.contributor.author | Hollander, Eric | |
dc.contributor.author | Grant, Jon E | |
dc.contributor.author | Chamberlain, Samuel R | |
dc.contributor.author | Drummond, Lynne | |
dc.contributor.author | Pellegrini, Luca | |
dc.contributor.author | Laws, Keith | |
dc.contributor.author | Wellsted, David | |
dc.contributor.author | Reid, Jemma | |
dc.contributor.author | Nezgovorova, Vera | |
dc.contributor.author | Baldwin, David | |
dc.date.accessioned | 2022-06-09T14:03:23Z | |
dc.date.available | 2022-06-09T14:03:23Z | |
dc.date.issued | 2022-06-01 | |
dc.identifier.citation | Fineberg , N , Hollander , E , Grant , J E , Chamberlain , S R , Drummond , L , Pellegrini , L , Laws , K , Wellsted , D , Reid , J , Nezgovorova , V & Baldwin , D 2022 , ' Commentary on the article: “Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation A Randomized Clinical Trial” ' , Comprehensive Psychiatry , vol. 116 , 152323 , pp. 152323 . https://doi.org/10.1016/j.comppsych.2022.152323 , https://doi.org/10.1016/j.comppsych.2022.152323 | |
dc.identifier.issn | 0010-440X | |
dc.identifier.other | ORCID: /0000-0002-2855-2865/work/121257617 | |
dc.identifier.other | ORCID: /0000-0002-5065-0867/work/124446479 | |
dc.identifier.other | ORCID: /0000-0002-2895-7838/work/114304114 | |
dc.identifier.uri | http://hdl.handle.net/2299/25554 | |
dc.description | © 2022 The Authors. Published by Elsevier Inc. This is an open access article distributed under the Creative Commons Non Commercial-No Derivatives Attribution License, to view a copy of the license, see: https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.format.extent | 2 | |
dc.format.extent | 225456 | |
dc.format.extent | 350649 | |
dc.language.iso | eng | |
dc.relation.ispartof | Comprehensive Psychiatry | |
dc.subject | Clinical Psychology | |
dc.subject | Psychiatry and Mental health | |
dc.title | Commentary on the article: “Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation A Randomized Clinical Trial” | en |
dc.contributor.institution | Centre for Health Services and Clinical Research | |
dc.contributor.institution | Cognitive Neuropsychology | |
dc.contributor.institution | School of Life and Medical Sciences | |
dc.contributor.institution | Department of Clinical, Pharmaceutical and Biological Science | |
dc.contributor.institution | Department of Psychology, Sport and Geography | |
dc.contributor.institution | Centre for Research in Psychology and Sport Sciences | |
dc.contributor.institution | Psychology | |
dc.contributor.institution | Psychology and NeuroDiversity Applied Research Unit | |
dc.contributor.institution | Health Research Methods Unit | |
dc.contributor.institution | Basic and Clinical Science Unit | |
dc.contributor.institution | Behaviour Change in Health and Business | |
dc.description.status | Peer reviewed | |
rioxxterms.versionofrecord | 10.1016/j.comppsych.2022.152323 | |
rioxxterms.type | Other | |
herts.preservation.rarelyaccessed | true | |